Cargando…

A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals

BACKGROUND: Nanomedicine is the medical application of nanomaterials that may have an infinite size with the range less than 100 nm. This science has provided solutions to many of the current limitations in the diagnosis and treatment of diseases. Therefore, the pharmacist’s knowledge and awareness...

Descripción completa

Detalles Bibliográficos
Autores principales: Assali, Mohyeddin, Shakaa, Ali, Abu-Hejleh, Sabaa, Abu-Omar, Reham, Karajeh, Nareman, Ajory, Nawal, Zyoud, Saed, Sweileh, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887200/
https://www.ncbi.nlm.nih.gov/pubmed/29622013
http://dx.doi.org/10.1186/s12913-018-3060-7
_version_ 1783312246858842112
author Assali, Mohyeddin
Shakaa, Ali
Abu-Hejleh, Sabaa
Abu-Omar, Reham
Karajeh, Nareman
Ajory, Nawal
Zyoud, Saed
Sweileh, Waleed
author_facet Assali, Mohyeddin
Shakaa, Ali
Abu-Hejleh, Sabaa
Abu-Omar, Reham
Karajeh, Nareman
Ajory, Nawal
Zyoud, Saed
Sweileh, Waleed
author_sort Assali, Mohyeddin
collection PubMed
description BACKGROUND: Nanomedicine is the medical application of nanomaterials that may have an infinite size with the range less than 100 nm. This science has provided solutions to many of the current limitations in the diagnosis and treatment of diseases. Therefore, the pharmacist’s knowledge and awareness of nano-pharmaceutical drugs will increase their availability in the market, and will improve the patient’s compliance to their drug therapy. This study aimed to determine the availability of nano-pharmaceutical drugs in Palestinian hospitals and evaluate the extent of pharmacist’s knowledge about them. METHODS: A cross-sectional study design questionnaire was used to determine the availability of nano-pharmaceutical drugs based on the database of the ministry of health in the Palestinian hospitals (governmental, private and non- governmental organizations). Moreover, the knowledge of these nano-pharmaceutical drugs among pharmacists working in Palestinian hospitals was assessed based on developed questionnaire from the literature of the pharmaceutical formulations and nano-formulations. The variables were analyzed using Statistical Package for Social Sciences (SPSS 22). RESULT: Fifty six pharmacists from 27 hospitals in the West bank completed the survey. The results regarding the availability of nano-pharmaceutical drugs indicated only eight available in hospitals with a frequency range 0–39.3%. Moreover, pharmacist’s knowledge in the pharmaceutical formulations was better than that in nano-formulations. CONCLUSIONS: The availability of nano-pharmaceutical drugs in Palestinian hospitals was not adequate due to the lack of various nano-pharmaceutical drugs. The knowledge among pharmacists regarding nano-pharmaceutical drugs should be improved by providing courses in nanomedicine during the undergraduate pharmacy programs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3060-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5887200
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58872002018-04-09 A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals Assali, Mohyeddin Shakaa, Ali Abu-Hejleh, Sabaa Abu-Omar, Reham Karajeh, Nareman Ajory, Nawal Zyoud, Saed Sweileh, Waleed BMC Health Serv Res Research Article BACKGROUND: Nanomedicine is the medical application of nanomaterials that may have an infinite size with the range less than 100 nm. This science has provided solutions to many of the current limitations in the diagnosis and treatment of diseases. Therefore, the pharmacist’s knowledge and awareness of nano-pharmaceutical drugs will increase their availability in the market, and will improve the patient’s compliance to their drug therapy. This study aimed to determine the availability of nano-pharmaceutical drugs in Palestinian hospitals and evaluate the extent of pharmacist’s knowledge about them. METHODS: A cross-sectional study design questionnaire was used to determine the availability of nano-pharmaceutical drugs based on the database of the ministry of health in the Palestinian hospitals (governmental, private and non- governmental organizations). Moreover, the knowledge of these nano-pharmaceutical drugs among pharmacists working in Palestinian hospitals was assessed based on developed questionnaire from the literature of the pharmaceutical formulations and nano-formulations. The variables were analyzed using Statistical Package for Social Sciences (SPSS 22). RESULT: Fifty six pharmacists from 27 hospitals in the West bank completed the survey. The results regarding the availability of nano-pharmaceutical drugs indicated only eight available in hospitals with a frequency range 0–39.3%. Moreover, pharmacist’s knowledge in the pharmaceutical formulations was better than that in nano-formulations. CONCLUSIONS: The availability of nano-pharmaceutical drugs in Palestinian hospitals was not adequate due to the lack of various nano-pharmaceutical drugs. The knowledge among pharmacists regarding nano-pharmaceutical drugs should be improved by providing courses in nanomedicine during the undergraduate pharmacy programs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12913-018-3060-7) contains supplementary material, which is available to authorized users. BioMed Central 2018-04-05 /pmc/articles/PMC5887200/ /pubmed/29622013 http://dx.doi.org/10.1186/s12913-018-3060-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Assali, Mohyeddin
Shakaa, Ali
Abu-Hejleh, Sabaa
Abu-Omar, Reham
Karajeh, Nareman
Ajory, Nawal
Zyoud, Saed
Sweileh, Waleed
A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals
title A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals
title_full A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals
title_fullStr A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals
title_full_unstemmed A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals
title_short A cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in Palestinian hospitals
title_sort cross-sectional study of the availability and pharmacist’s knowledge of nano-pharmaceutical drugs in palestinian hospitals
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887200/
https://www.ncbi.nlm.nih.gov/pubmed/29622013
http://dx.doi.org/10.1186/s12913-018-3060-7
work_keys_str_mv AT assalimohyeddin acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT shakaaali acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT abuhejlehsabaa acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT abuomarreham acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT karajehnareman acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT ajorynawal acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT zyoudsaed acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT sweilehwaleed acrosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT assalimohyeddin crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT shakaaali crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT abuhejlehsabaa crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT abuomarreham crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT karajehnareman crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT ajorynawal crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT zyoudsaed crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals
AT sweilehwaleed crosssectionalstudyoftheavailabilityandpharmacistsknowledgeofnanopharmaceuticaldrugsinpalestinianhospitals